S.Korea authorises emergency use of Pfizer's oral coronavirus treatment


  • World
  • Monday, 27 Dec 2021

FILE PHOTO: Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS

SEOUL (Reuters) -South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety said on Monday.

South Korea restored tough distancing curbs last week after easing them in November, after a series of record daily new infections and serious cases stretched medical services, despite a vaccination rate of over 92% for those aged 18 or older.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Teenager charged with terrorism over Sydney bishop stabbing
UK PM Sunak to consult on tougher rules to combat 'sick note culture'
Weekly storage of natural gas in U.S. increases: EIA
U.S. stocks end mixed, S&P 500 down for 5th day
Canada to host UN event for global solution to end plastic pollution
U.S. stocks close mixed
India votes in gigantic election as Modi seeks historic third term
Crude futures settle mixed
Bosch Group to harness climate action for future growth
U.S. dollar ticks up

Others Also Read